MARATTO

article · OALib

CT-Scan Evaluation of Acute Pulmonary Embolism: About 63 Thoracic CT-Angiographies at the Rock Medical Imaging Center (CIMR/Kinshasa)

20231 citationOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

Background and objective: Pulmonary embolism (PE) is a serious pathology with high mortality. The clinical signs of pulmonary embolism are not very specific. Thoracic CT-angiography is the examination of choice in confirming the diagnosis of PE. Our objective was to describe the epidemiological-clinical, tomographic and progressive aspects of patients. Methods: A single-center descriptive and analytical observational study of a series of 63 patients received at the CIMR over a period of 24 months. Results: The incidence of acute pulmonary embolism was 25.6%. The average age of the patients was 66.5 9.3 years with a F/M sex ratio of 1.6. Most patients had a PESI score ranging from I to III (31.8%, 28.6%, 19.1%). All patients with non-massive PE were stable, while 2 patients with massive PE (37.5%) died (p = 0.001). The Qanadli score (QS) was higher in the deceased (64.5% 2.1%) compared to the living (46% 11.8%) (p = 0.0313). The mean LV of patients with massive embolism was low compared to patients with non-massive embolism (p = 0.005). The pulmonary artery which was larger in patients with massive embolism (p = 0.007) compared to patients with non-massive embolism. The same for the aorta (p = 0.035). The RV/LV ratio was higher in patients with massive PE compared to stable patients (1.7 vs 1.1 p = 0.001).

Research topics

  • Venous Thromboembolism Diagnosis and Management
  • Ultrasound in Clinical Applications

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4236/oalib.1110811

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.